Vincent Ciuryla

1.0k total citations
18 papers, 824 citations indexed

About

Vincent Ciuryla is a scholar working on Epidemiology, Gastroenterology and General Health Professions. According to data from OpenAlex, Vincent Ciuryla has authored 18 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 3 papers in Gastroenterology and 2 papers in General Health Professions. Recurrent topics in Vincent Ciuryla's work include Pneumonia and Respiratory Infections (9 papers), Respiratory viral infections research (7 papers) and Influenza Virus Research Studies (3 papers). Vincent Ciuryla is often cited by papers focused on Pneumonia and Respiratory Infections (9 papers), Respiratory viral infections research (7 papers) and Influenza Virus Research Studies (3 papers). Vincent Ciuryla collaborates with scholars based in United States, Canada and Germany. Vincent Ciuryla's co-authors include Gabrielle Ciesla, Larry Liu, L. Clark Paramore, Derek Weycker, Gerry Oster, Azhar Nizam, Ira M. Longini, M. Elizabeth Halloran, John Edelsberg and G. Thomas Ray and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and Fuel.

In The Last Decade

Vincent Ciuryla

15 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Ciuryla United States 11 640 135 119 107 99 18 824
Nan-Chang Chiu Taiwan 13 259 0.4× 46 0.3× 321 2.7× 83 0.8× 67 0.7× 28 739
Lisa McHugh Australia 15 288 0.5× 66 0.5× 79 0.7× 41 0.4× 110 1.1× 38 589
Alejandro Cané United States 17 427 0.7× 118 0.9× 213 1.8× 47 0.4× 121 1.2× 56 688
Pekka Honkanen Finland 13 548 0.9× 90 0.7× 55 0.5× 102 1.0× 118 1.2× 28 695
Judith A. Guzman‐Cottrill United States 14 313 0.5× 42 0.3× 443 3.7× 151 1.4× 48 0.5× 45 970
David Moreno‐Pérez Spain 14 557 0.9× 181 1.3× 226 1.9× 160 1.5× 99 1.0× 84 773
Pia Toikka Finland 8 674 1.1× 191 1.4× 83 0.7× 71 0.7× 27 0.3× 9 732
Sarah S. Long United States 12 835 1.3× 141 1.0× 221 1.9× 204 1.9× 107 1.1× 22 1.0k
Jitendra Singh India 15 309 0.5× 29 0.2× 456 3.8× 78 0.7× 93 0.9× 62 944
Natalie Woon Hui Tan Singapore 14 197 0.3× 54 0.4× 425 3.6× 60 0.6× 22 0.2× 39 764

Countries citing papers authored by Vincent Ciuryla

Since Specialization
Citations

This map shows the geographic impact of Vincent Ciuryla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Ciuryla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Ciuryla more than expected).

Fields of papers citing papers by Vincent Ciuryla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Ciuryla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Ciuryla. The network helps show where Vincent Ciuryla may publish in the future.

Co-authorship network of co-authors of Vincent Ciuryla

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Ciuryla. A scholar is included among the top collaborators of Vincent Ciuryla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Ciuryla. Vincent Ciuryla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pelton, Stephen I., Derek Weycker, Jerome O. Klein, et al.. (2009). 7-Valent pneumococcal conjugate vaccine and lower respiratory tract infections: Effectiveness of a 2-dose versus 3-dose primary series. Vaccine. 28(6). 1575–1582. 25 indexed citations
2.
Snedecor, Sonya J., David Strutton, Vincent Ciuryla, Elissa J. Schwartz, & Marc Botteman. (2009). Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populations. Vaccine. 27(34). 4694–4703. 16 indexed citations
3.
Isaacman, Daniel J., David Strutton, N. Horowicz-Mehler, et al.. (2008). The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine. Clinical Therapeutics. 30(2). 341–357. 36 indexed citations
4.
Tinkelman, David, Rezaul Karim Khandker, Brian Calimlim, et al.. (2007). ABSENTEEISM FROM SCHOOL OR WORK AMONG UNCONTROLLED ASTHMA PATIENTS. CHEST Journal. 132(4). 484A–484A. 1 indexed citations
5.
Ray, G. Thomas, Cynthia G. Whitney, Bruce Fireman, Vincent Ciuryla, & Steven Black. (2006). Cost-Effectiveness of Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal. 25(6). 494–501. 128 indexed citations
6.
Isaacman, Daniel J., Mark A. Fletcher, Bernard Fritzell, Vincent Ciuryla, & Jennifer Schranz. (2006). Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar). Vaccine. 25(13). 2420–2427. 37 indexed citations
7.
Weycker, Derek, John Edelsberg, M. Elizabeth Halloran, et al.. (2004). Population-wide benefits of routine vaccination of children against influenza. Vaccine. 23(10). 1284–1293. 215 indexed citations
8.
Paramore, L. Clark, Vincent Ciuryla, Gabrielle Ciesla, & Larry Liu. (2004). Economic Impact of Respiratory Syncytial Virus-Related Illness in the US. PharmacoEconomics. 22(5). 275–284. 169 indexed citations
9.
Lorente, M.A., et al.. (2004). A Pharmacoeconomic Evaluation of Seven-Valent Pneumococcal Conjugate Vaccine in Spain. Value in Health. 7(1). 36–51. 36 indexed citations
10.
Lebel, Marc, James D. Kellner, E. Lee Ford‐Jones, et al.. (2003). A Pharmacoeconomic Evaluation of 7‐Valent Pneumococcal Conjugate Vaccine in Canada. Clinical Infectious Diseases. 36(3). 259–268. 44 indexed citations
11.
Paramore, Clark, et al.. (2003). PCV45: HOSPITALIZARON EXPENDITURE OF ACUTE RHEUMATIC FEVER AND CHRONIC RHEUMATIC HEART DISEASE IN THE UNITED STATES. Value in Health. 6(3). 323–324. 1 indexed citations
12.
Paramore, Clark, et al.. (2002). PIN4 ECONOMIC IMPACT OF RESPIRATORY SYNCYTIAL VIRUS INFECTION ON HEALTHCARE RESOURCE UTILIZATION AND COSTS IN THE UNITED STATES. Value in Health. 5(3). 257–257. 1 indexed citations
13.
Arikian, Steven R., et al.. (2000). PHV14: A MULTINATIONAL PHARMACOECONOMIC EVALUATION OF THE SEVEN-VALENT PNEUMOCOCCAL CONJUGATE VACCINE. Value in Health. 3(2). 121–122. 3 indexed citations
14.
Johnson, Richard J., et al.. (2000). A COMPARISON OF NISOLDIPINE ER AND AMLODIPINE FOR THE TREATMENT OF MILD TO MODERATE HYPERTENSION. International Journal of Clinical Practice. 54(8). 509–513. 5 indexed citations
15.
Flynn, James P., et al.. (2000). PHV27: COSTS AND OUTCOMES OF TREATING FEBRILE NEUTROPENIA IN NINE EUROPEAN COUNTRIES. Value in Health. 3(2). 126–126. 1 indexed citations
16.
Oster, Gerry, Derek Weycker, Vincent Ciuryla, Edward P. Richardson, & Dorothea K. Thompson. (2000). PHV15: CLINICAL AND ECONOMIC BENEFITS OF THE PNEUMOCOCCAL CONJUGATE VACCINE IN CHILDREN. Value in Health. 3(2). 122–122. 2 indexed citations
17.
Ciuryla, Vincent, et al.. (1979). Ambient-pressure thermogravimetric characterization of four different coals and their chars. Fuel. 58(10). 748–754. 43 indexed citations
18.
Goldstick, Thomas K., Vincent Ciuryla, & L Zuckerman. (1976). Diffusion of Oxygen in Plasma and Blood. Advances in experimental medicine and biology. 75. 183–190. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nan-Chang Chiu Breakdown of academic impact, for papers by Lisa McHugh Breakdown of academic impact, for papers by Alejandro Cané Breakdown of academic impact, for papers by Pekka Honkanen Breakdown of academic impact, for papers by Judith A. Guzman‐Cottrill Breakdown of academic impact, for papers by David Moreno‐Pérez Breakdown of academic impact, for papers by Pia Toikka Breakdown of academic impact, for papers by Sarah S. Long Breakdown of academic impact, for papers by Jitendra Singh Breakdown of academic impact, for papers by Natalie Woon Hui Tan
Rankless by CCL
2026